The Company’s pharmaceutical supply chain business generates gross margin primarily to the extent that the selling price to its customers, net of customer discounts, exceeds in the aggregate, the cost of products sold, net of manufacturer cash discounts, distribution service agreement fees, pharmaceutical price appreciation and manufacturer rebates and incentives.
Before, with commentary
How far did you get into that equation before your eyes glazed over?
Our pharmaceutical supply chain business generates gross margin primarily when:
The aggregate selling prices to our customers, net of customer discounts
The aggregate cost of products sold, net of
• Manufacturer cash discounts
• Distribution service agreement fees
• Pharmaceutical price appreciation
• Manufacturer rebates and incentives